Ritonavir boosting: Rethinking old tools for new public health challenges

  • BC-CfE Update – Spring 2025
Presenter:
Dr. Anil Maharaj
Assistant Professor, Faculty of Pharmaceutical Sciences
The University of British Columbia
Share this video:
All Videos
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search